- Home
- GH vs MTDR Comparison
GH vs MTDR Comparison
Compare GH & MTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GH
- MTDR
- Stock Information
- Founded
- GH 2011
- MTDR 2003
- Country
- GH United States
- MTDR United States
- Employees
- GH N/A
- MTDR N/A
- Industry
- GH Medical Specialities
- MTDR Oil & Gas Production
- Sector
- GH Health Care
- MTDR Energy
- Exchange
- GH Nasdaq
- MTDR Nasdaq
- Market Cap
- GH 5.5B
- MTDR 5.1B
- IPO Year
- GH 2018
- MTDR 2012
- Fundamental
- Price
- GH $40.62
- MTDR $43.03
- Analyst Decision
- GH Strong Buy
- MTDR Buy
- Analyst Count
- GH 21
- MTDR 14
- Target Price
- GH $52.81
- MTDR $69.36
- AVG Volume (30 Days)
- GH 2.3M
- MTDR 1.6M
- Earning Date
- GH 04-30-2025
- MTDR 07-22-2025
- Dividend Yield
- GH N/A
- MTDR 2.50%
- EPS Growth
- GH N/A
- MTDR 1.98
- EPS
- GH N/A
- MTDR 7.44
- Revenue
- GH $773,996,000.00
- MTDR $3,437,988,000.00
- Revenue This Year
- GH $23.05
- MTDR $17.54
- Revenue Next Year
- GH $21.40
- MTDR $0.79
- P/E Ratio
- GH N/A
- MTDR $5.78
- Revenue Growth
- GH 28.20
- MTDR 21.69
- 52 Week Low
- GH $20.14
- MTDR $35.19
- 52 Week High
- GH $52.92
- MTDR $66.89
- Technical
- Relative Strength Index (RSI)
- GH 48.45
- MTDR 47.87
- Support Level
- GH $37.73
- MTDR $42.41
- Resistance Level
- GH $39.63
- MTDR $44.67
- Average True Range (ATR)
- GH 1.60
- MTDR 1.14
- MACD
- GH -0.01
- MTDR 0.03
- Stochastic Oscillator
- GH 60.00
- MTDR 14.22
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
About MTDR Matador Resources Company
Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business.